Use of the Pfizer-BioNTech covid-19 vaccine in people with a history of severe allergies was temporarily stopped in […]
ABSTRACTNon-alcoholic fatty liver disease is a very common medical condition, driven by a combination of genetic and lifestyle […]
Investments in health research are not fully realised because of delayed and variable uptake of effective interventions by […]
Partnership aims to transform HIV patient care with digital services
Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma
Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia
Approval is based on results from the Phase III DESTINY-Gastric01 trial
Updated Date: Fri, 08 Jan 2021 00:00:00 EST
Updated Date: Fri, 08 Jan 2021 00:00:00 EST
